Apoptotic Cell Death in Neuroblastoma
Open Access
Abstract
Neuroblastoma (NB) is one of the most common malignant solid tumors in childhood, which derives from the sympathoadrenal lineage of the neural crest and exhibits extremely heterogeneous biological and clinical behaviors. The infant patients frequently undergo spontaneous regression even with metastatic disease, whereas the patients of more than one year of age who suffer from disseminated disease have a poor outcome despite intensive multimodal treatment. Spontaneous regression in favorable NBs has been proposed to be triggered by nerve growth factor (NGF) deficiency in the tumor with NGF dependency for survival, while aggressive NBs have defective apoptotic machinery which enables the tumor cells to evade apoptosis and confers the resistance to treatment. This paper reviews the molecules and pathways that have been recently identified to be involved in apoptotic cell death in NB and discusses their potential prospects for developing more effective therapeutic strategies against aggressive NB.Keywords
This publication has 196 references indexed in Scilit:
- Wnt/β-Catenin Signaling and DiseaseCell, 2012
- Integrative genomics identifies LMO1 as a neuroblastoma oncogeneNature, 2010
- p73 regulates maintenance of neural stem cellBiochemical and Biophysical Research Communications, 2010
- NF1 Is a Tumor Suppressor in Neuroblastoma that Determines Retinoic Acid Response and Disease OutcomeCell, 2010
- Autophagy: cellular and molecular mechanismsThe Journal of Pathology, 2010
- BH3 response profiles from neuroblastoma mitochondria predict activity of small molecule Bcl-2 family antagonistsCell Death & Differentiation, 2009
- ZNF423 Is Critically Required for Retinoic Acid-Induced Differentiation and Is a Marker of Neuroblastoma OutcomeCancer Cell, 2009
- Interplay among BRCA1, SIRT1, and Survivin during BRCA1-Associated TumorigenesisMolecular Cell, 2008
- Identification of ALK as a major familial neuroblastoma predisposition geneNature, 2008
- Myc suppression of the p21Cip1 Cdk inhibitor influences the outcome of the p53 response to DNA damageNature, 2002